Taro Iwamoto

1.4k total citations
41 papers, 933 citations indexed

About

Taro Iwamoto is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Taro Iwamoto has authored 41 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 17 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Taro Iwamoto's work include Systemic Lupus Erythematosus Research (12 papers), T-cell and B-cell Immunology (9 papers) and Inflammatory Myopathies and Dermatomyositis (8 papers). Taro Iwamoto is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), T-cell and B-cell Immunology (9 papers) and Inflammatory Myopathies and Dermatomyositis (8 papers). Taro Iwamoto collaborates with scholars based in Japan, United States and United Kingdom. Taro Iwamoto's co-authors include Hiroshi Nakajima, Shunsuke Furuta, Kei Ikeda, Kotaro Suzuki, Shigeru Tanaka, Yoshie Sanayama, Timothy B. Niewold, Daiki Nakagomi, Akira Suto and Hiroaki Takatori and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Taro Iwamoto

38 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taro Iwamoto Japan	13	513	323	201	125	123	41	933
Francesca Bellisai Italy	21	611 1.2×	313 1.0×	200 1.0×	135 1.1×	234 1.9×	62	1.1k
Daiki Nakagomi Japan	16	470 0.9×	181 0.6×	355 1.8×	76 0.6×	107 0.9×	61	906
Ippei Miyagawa Japan	16	549 1.1×	408 1.3×	96 0.5×	90 0.7×	81 0.7×	72	904
Yusuke Miyazaki Japan	16	628 1.2×	554 1.7×	87 0.4×	106 0.8×	88 0.7×	60	993
Kimihiro Suzuki Japan	16	291 0.6×	244 0.8×	212 1.1×	103 0.8×	103 0.8×	59	869
Kyriaki Boki Greece	21	761 1.5×	347 1.1×	273 1.4×	124 1.0×	72 0.6×	54	1.2k
Sandra Muñoz Spain	6	428 0.8×	216 0.7×	153 0.8×	163 1.3×	39 0.3×	7	805
D. Boumpas Greece	9	514 1.0×	246 0.8×	137 0.7×	50 0.4×	91 0.7×	17	871
Ziyan Wu China	14	278 0.5×	170 0.5×	87 0.4×	115 0.9×	128 1.0×	68	638
Ayako Nishino Japan	14	325 0.6×	229 0.7×	116 0.6×	64 0.5×	175 1.4×	48	647

Countries citing papers authored by Taro Iwamoto

Since Specialization

Citations

This map shows the geographic impact of Taro Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Iwamoto more than expected).

Fields of papers citing papers by Taro Iwamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Iwamoto. The network helps show where Taro Iwamoto may publish in the future.

Co-authorship network of co-authors of Taro Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Iwamoto. A scholar is included among the top collaborators of Taro Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Iwamoto. Taro Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iwamoto, Taro, et al.. (2025). Rapid resolution of fever and panniculitis after anifrolumab in a patient with systemic lupus erythematosus refractory to standard immunosuppression. Immunological Medicine. 49(1). 102–106.

Furuta, Shunsuke, Michio Fujiwara, Masaki Hiraguri, et al.. (2024). Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis. Lara D. Veeken. 64(2). 756–762. 3 indexed citations

Iwamoto, Taro, Y Kobayashi, Arifumi Iwata, et al.. (2024). Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD Open. 10(1). e003902–e003902. 6 indexed citations

Abe, Kazuya, Taro Iwamoto, Kei Ikeda, et al.. (2024). Calcium pyrophosphate crystal arthritis associated with immune checkpoint inhibitor successfully treated with intra-articular glucocorticoid: A case report. Modern Rheumatology Case Reports. 9(1). 27–30.

Tanaka, Shigeru, Kei Ikeda, Takahiro Kageyama, et al.. (2023). CCR4 predicts the efficacy of abatacept in rheumatoid arthritis patients through the estimation of Th17 and Treg cell abundance. Modern Rheumatology. 34(4). 700–704. 1 indexed citations

Furuta, Shunsuke, Yuki Hayashi, Kazuya Abe, et al.. (2023). Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD Open. 9(1). e002795–e002795. 32 indexed citations

Abe, Kazuya, Shunsuke Furuta, Y Kobayashi, et al.. (2023). Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD Open. 9(1). e002770–e002770. 11 indexed citations

Ikeda, Kei, Hiroyuki Ohbe, K Nakamura, et al.. (2023). Early initiation of angiotensin-converting enzyme inhibitor in patients with scleroderma renal crisis: a nationwide inpatient database study. Lara D. Veeken. 63(6). 1507–1511. 4 indexed citations

Iwamoto, Taro, J. Suzuki, Takahiro Sugiyama, et al.. (2023). Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis. Arthritis Research & Therapy. 25(1). 26–26. 18 indexed citations

10.

Iwamoto, Taro, Y Kobayashi, Fumio Takizawa, et al.. (2023). POS0572 IMMUNOGENICITY AND SAFETY OF ADJUVANTED RECOMBINANT ZOSTER VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS. Annals of the Rheumatic Diseases. 82. 554–555. 1 indexed citations

11.

Tanaka, Shigeru, Junichi Ishikawa, Taro Iwamoto, et al.. (2022). Visceral disseminated varicella zoster virus infection during non-intensive maintenance therapy in a patient with systemic lupus erythematosus. Modern Rheumatology Case Reports. 7(1). 57–59. 4 indexed citations

12.

Kageyama, Takahiro, Shigeru Tanaka, Taro Iwamoto, et al.. (2022). Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2. Vaccine. 40(14). 2129–2133. 1 indexed citations

13.

Ikeda, Kei, Takahiro Sugiyama, Shigeru Tanaka, et al.. (2021). Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis. PLoS ONE. 16(5). e0252116–e0252116. 8 indexed citations

14.

Nakajima, Mikio, Kei Ikeda, K Nakamura, et al.. (2021). Prognosis and Treatment of Myositis‐Associated Severe Interstitial Lung Disease: A Descriptive Study Using a Nationwide Inpatient Database in Japan. Arthritis Care & Research. 74(3). 478–483. 5 indexed citations

15.

Suzuki, Kazumasa, Kotaro Suzuki, Junichi Ishikawa, et al.. (2021). NF-κB1 Contributes to Imiquimod-Induced Psoriasis-Like Skin Inflammation by Inducing Vγ4+Vδ4+γδT17 Cells. Journal of Investigative Dermatology. 142(6). 1639–1649.e5. 8 indexed citations

16.

Iwamoto, Taro, Jessica M. Dorschner, Shanmugapriya Selvaraj, et al.. (2021). High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis. The Journal of Rheumatology. 49(4). 388–397. 25 indexed citations

17.

Suto, Akira, Arifumi Iwata, Taro Iwamoto, et al.. (2020). Sox12 enhances Fbw7-mediated ubiquitination and degradation of GATA3 in Th2 cells. Cellular and Molecular Immunology. 18(7). 1729–1738. 23 indexed citations

18.

Tanaka, Shigeru, Akira Suto, Taro Iwamoto, et al.. (2018). Sox12 promotes T reg differentiation in the periphery during colitis. The Journal of Experimental Medicine. 215(10). 2509–2519. 11 indexed citations

19.

Kageyama, Takahiro, Akira Suto, Taro Iwamoto, et al.. (2017). IL-21 Exacerbates Autoimmune Myositis by Enhancing the Accumulation of GM-CSF–Producing γδ T Cells in the Muscle. ImmunoHorizons. 1(8). 176–187. 5 indexed citations

20.

Ikeda, Kei, Daiki Nakagomi, Yoshie Sanayama, et al.. (2013). Correlation of Radiographic Progression with the Cumulative Activity of Synovitis Estimated by Power Doppler Ultrasound in Rheumatoid Arthritis: Difference Between Patients Treated with Methotrexate and Those Treated with Biological Agents. The Journal of Rheumatology. 40(12). 1967–1976. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact